Heart failure Flashcards

1
Q

three main underlying causes of heart failure

A

coronary artery disease
diabetes mellitus
hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

heart failure may also be called

A

congestive heart failure CHF
congestive cardiac failure CCF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathogenesis of heart failure

A

pressure or volume overload increases the work on the myocardium
this is initially compensated by cardiac hypertrophy
chronic overload leads to decompensation where the cardiomyocytes lose their contractility
stroke volume and output is reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

classification by ejection fraction

A

HFrEF (reduced): <40%, (previously called systolic failure)
HFmrEF (mildly reduced): 40-49%
FHpEF(preserved): >50%, ( previously called diastolic failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

symptoms at presentaton

A

dyspnoea
cough
fatigue
poor exercise tolerance
ankle swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

signs at presentation

A

tachycardia
additional heart sounds/murmurs
elevated jugular venous pressure
tachypnoea
bilateral lung base crackles
enlarged liver
peripheral oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ECG might show

A

acute or previous ischaemia, arrhythmia and other abnormalities that may suggest causative or exacerbating aetiologies such as IHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

laboritory tests

A

FBC, UECs, LFTs, troponin, BSL
consider serum BNP or NT-proBNP when diagnosis unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

imaging

A

CXR - classic findings include alveolar oedema, Kerley B lines, cardiomegaly, upper lobe diversion and pleural effusion
echocardiography - can differentiate between HFrEF and HFpEF, s well s highlight other abnormalities or causative factors
may also consider stress testing or cardiac MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

differential diagnosis

A

for shortness of breath:
- COPD, sleep apnoea
for peripheral oedema:
- venous insufficiency, thrombosis
- CKD and/or nephrotic syndrome
- cirrhosis
- calcium-channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

specific treatments for underlying causes

A

lower blood pressure
revascularisation or drug therapy for coronary artery disease
manage diabetes
arrythmias
excess alcohol intake
use of recreational stimulant drugs
cardaic amyloidosis, haemochromatosis, thalassaemia, chemotherapy toxicity)
valvular heart ddisease
hyperthyroidism
chronic lung disease
pulmonary embolism
pericardial effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drug therapy for HFrEF

A

all patients with HfrEF should be started on
ACEI/ARB
beta blocker
aldosterone antagonist
SGLT2
Loop diuretic can be dded to therapy at any stage to control symptoms of congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when should you add the bet blocker

A

once the patient is euvolaemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

first line choices for ACEI/ARB

A

either an ACE or sacubitril+valsartan (non-pbs)
ARBs are second line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

starting the patient on a beta blocker

A

can initially worsen the symptoms
do not start during acute decompensation or if the patient has congestion
start with low dose and increase gradually
monitor symptoms and measure weight daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

beta blocker examples

A

bisoprolol
nebivolol
metoprolol succinate

17
Q

starting aldosterone antgonist

A

eg. eplerenone or spironolactone

18
Q

hyperkalaemia risk

A

in patients with kidney impairment
the combnation of aldosterone antagonist and renin-angiotensin system inhibitor cn cause life threatening hyperkalaemia
a small rise in serum potassium (within normal range) may occur and may be transient

19
Q

starting an SGLT2

A

eg. dapagliflozin or empagliflozin

20
Q

when to start a loop diuretic

A

can be used in patients with heart failure to reduce signs and symptoms of congestion
eg. furosemide or bumetanide

21
Q

how to treat patients with HFpEF

A

SGLT2 inhibitor eg. empagliflozin and dapagliflozin
this is the only routine drug that should be prescribed for all patients with HFpEF

22
Q

what else might you prescribe for someone with HFpEF

A

drugs for their comorbidities/underlying causes
eg. blood pressure reducing medication, beta blockers for afib or fast resting ventricualr rate or coexisting coronary artery disease

23
Q

lifestyle advice for HF

A

drug management to support adherance
fluid management advice
sodium restriction advice
- no added salt diet, excessive salt intake can precipitate or worsen heart failure
regular assessment for depression
- depression is a common comorbidity
obesity management advice
dietitian input
physical activity support

24
Q

drug management advice to support adherance might include

A
  • when and why dose adjustments are needed
  • adverse events
  • regurlalry updated drug list should be supplied to care team
  • do not use NSAIDs or pseudoephidrine
25
Q

fluid mangement advice might include

A
  • use daily weight charts as an indictor of fluid retention
  • use fluid management program
  • limit fluid intake to 1.5L per day
  • manage night time symptoms with recliner or extra pillows
26
Q

complications of HF

A

pleural effusion
acute decompensation of CHF
sudden cardiac death
acute renal failure
chronic renal insufficiency
anaemia

27
Q
A